EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists.
Expert recommendations
Female cancer patients
Fertility preservation
Haematologists
Oncofertility
Oncologists
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
19
07
2018
revised:
25
10
2018
accepted:
20
03
2019
pubmed:
17
5
2019
medline:
5
7
2019
entrez:
17
5
2019
Statut:
ppublish
Résumé
In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.
Identifiants
pubmed: 31092380
pii: S1040-8428(18)30328-7
doi: 10.1016/j.critrevonc.2019.03.010
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Consensus Development Conference
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-240Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.